Literature DB >> 17198790

The murine bronchopulmonary microcirculation in hapten-induced inflammation.

Dino J Ravnic1, Moritz A Konerding, Juan P Pratt, Tanja Wolloscheck, Harold T Huss, Steven J Mentzer.   

Abstract

OBJECTIVE: The clinical observation of central bronchial artery hypertrophy in chronic lung inflammation suggests the possibility that the bronchial circulation may also participate in adaptive responses in peripheral lung inflammation.
METHODS: To investigate the potential role of the bronchial microcirculation in peripheral lung inflammation, we developed a murine model of lung inflammation using the intratracheal instillation of the peptide-hapten trinitrophenol in presensitized mice.
RESULTS: Clinical parameters indicated a peak inflammatory response at 96 hours. Similarly, gross and microscopic evidence of inflammation was observed 96 hours after antigen instillation. Using a forced oscillation technique to probe peripheral lung mechanics at 96 hours, we detected no change in central airway resistance (P > .05), but a significant increase in peripheral tissue resistance (P < .05). The structure of the bronchial circulation was investigated by microsphere occlusion of the pulmonary circulation and corrosion casting of the bronchial circulation. SEM of the bronchial artery casts demonstrated (1) the presence of the peripheral bronchial circulation in mice, (2) interconnections of the two systems in the distal bronchial arteries and at the level of alveolar capillaries, and (3) functional evidence of increased bronchial perfusion of alveolar capillaries during mononuclear inflammation.
CONCLUSION: These results suggest an important adaptive role of the bronchial circulation in pulmonary inflammation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17198790     DOI: 10.1016/j.jtcvs.2006.08.054

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  8 in total

1.  Neovascularization in the pulmonary endothelium is regulated by the endosome: Rab4-mediated trafficking and p18-dependent signaling.

Authors:  Havovi Chichger; Julie Braza; Huetran Duong; Myranda Stark; Elizabeth O Harrington
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-08-07       Impact factor: 5.464

2.  Structural and functional evidence for the scaffolding effect of alveolar blood vessels.

Authors:  Barry C Gibney; Willi L Wagner; Alexandra B Ysasi; Janeil M Belle; Akira Tsuda; Maximilian Ackermann; Steven J Mentzer
Journal:  Exp Lung Res       Date:  2017-12-05       Impact factor: 2.459

Review 3.  Animal models of chronic obstructive pulmonary disease.

Authors:  Joanne L Wright; Manuel Cosio; Andrew Churg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-05-02       Impact factor: 5.464

4.  Naïve T cells re-distribute to the lungs of selectin ligand deficient mice.

Authors:  John R Harp; Thandi M Onami
Journal:  PLoS One       Date:  2010-06-04       Impact factor: 3.240

Review 5.  Angioplasticity in asthma.

Authors:  Kewal Asosingh; Serpil C Erzurum
Journal:  Biochem Soc Trans       Date:  2009-08       Impact factor: 5.407

6.  Angiogenesis gene expression in murine endothelial cells during post-pneumonectomy lung growth.

Authors:  Miao Lin; Kenji Chamoto; Barry C Gibney; Grace S Lee; Dinee Collings-Simpson; Jan Houdek; Moritz A Konerding; Akira Tsuda; Steven J Mentzer
Journal:  Respir Res       Date:  2011-07-27

Review 7.  Synapomorphic features of hepatic and pulmonary vasculatures include comparable purinergic signaling responses in host defense and modulation of inflammation.

Authors:  Dusan Hanidziar; Simon C Robson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-06-09       Impact factor: 4.871

8.  Lung-homing of endothelial progenitor cells and airway vascularization is only partially dependant on eosinophils in a house dust mite-exposed mouse model of allergic asthma.

Authors:  Nirooya Sivapalan; Jennifer Wattie; Mark D Inman; Roma Sehmi
Journal:  PLoS One       Date:  2014-10-03       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.